Advanced Glycation End Products and Cardiovascular Disease

被引:57
|
作者
Peppa, Melpomeni [1 ]
Raptis, Sotirios A. [1 ]
机构
[1] Attikon Univ Hosp, Res Inst & Diabet Ctr & Hel lenic Natl Diabet Ctr, Dept Internal Medicine Propaedeut 2, Endocrine Unit, Athens, Greece
关键词
Cardiovascular disease; Atherosclerosis; Oxidative stress; Inflammation; Arterial stiffening; Endothelium; Diet; Advanced glycation end products; AGEs; AGE-receptors; AGE-inhibitors; AGE-breakers;
D O I
10.2174/157339908784220732
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular disease (CVD) is the leading cause of mortality worldwide. Advanced glycation end products [AGEs] seem to play an important role for the development and/or progression of CVD mainly through induction of oxidative stress and inflammation. AGEs are a heterogenous group of molecules formed by the nonenzymatic reaction of reducing sugars with amino acids of proteins, lipids and nucleic acids. Recent studies suggest that in addition to those endogenously formed, diet constitutes an important exogenous source of AGEs. Diet-derived AGEs contribute to the whole body AGE pool and the AGE-related pathology. Recent in vitro and in vivo studies revealed significant correlations between diet-derived AGEs and several risk factors and/ or markers of CVD, suggesting the dietary AGEs restriction as a promising therapeutic intervention.
引用
收藏
页码:92 / 100
页数:9
相关论文
共 50 条
  • [1] Role of advanced glycation end products in cardiovascular disease
    Hegab, Zeinab
    Gibbons, Stephen
    Neyses, Ludwig
    Mamas, Mamas A.
    WORLD JOURNAL OF CARDIOLOGY, 2012, 4 (04): : 90 - 102
  • [2] Advanced Glycation End Products And And Incident Cardiovascular Disease
    Lamprea-Montealegre, Julio A.
    Arnold, Alice
    McClelland, Robyn
    Tracy, Russell P.
    Djousse, Luc
    Mukamal, Kenneth J.
    Psaty, Bruce M.
    Siscovick, David S.
    Zieman, Susan J.
    Brownlee, Michael
    Biggs, Mary Lou
    Beisswenger, Paul J.
    Ix, Joachim H.
    Kizer, Jorge R.
    CIRCULATION, 2021, 143
  • [3] Advanced Glycation End Products and Diabetic Cardiovascular Disease
    Prasad, Anand
    Bekker, Peter
    Tsimikas, Sotirios
    CARDIOLOGY IN REVIEW, 2012, 20 (04) : 177 - 183
  • [4] Advanced Glycation End Products and Their Involvement in Cardiovascular Disease
    Yubero-Serrano, Elena M.
    Perez-Martinez, Pablo
    ANGIOLOGY, 2020, 71 (08) : 698 - 700
  • [5] Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women
    Magdalena Pertynska-Marczewska
    Zaher Merhi
    Reproductive Sciences, 2015, 22 : 774 - 782
  • [6] Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women
    Pertynska-Marczewska, Magdalena
    Merhi, Zaher
    REPRODUCTIVE SCIENCES, 2015, 22 (07) : 774 - 782
  • [7] Advanced Glycation End Products: A Sweet Flavor That Embitters Cardiovascular Disease
    Pinto, Raphael S.
    Minanni, Carlos A.
    de Araujo Lira, Aecio Lopes
    Passarelli, Marisa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [8] Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis
    Pinto, R. S.
    Machado, U. F.
    Passarelli, M.
    BIOMARKERS IN MEDICINE, 2020, 14 (08) : 611 - 614
  • [9] Rheumatoid arthritis: links with cardiovascular disease and the receptor for advanced glycation end products
    Carroll, Lisa
    Hannawi, Suad
    Marwick, Thomas
    Thomas, Ranjeny
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2006, 156 (1-2) : 42 - 52
  • [10] Advanced glycation end-products as a potential target for treatment of cardiovascular disease
    Silacci, P
    JOURNAL OF HYPERTENSION, 2002, 20 (08) : 1483 - 1485